Shareholders in InDex Pharmaceuticals Holding AB as of March 31, 2022.
Shareholder | Number of Shares | Ownership, % | Votes, % |
---|---|---|---|
Linc AB | 69,920,567 | 13.1% | 13.1% |
HBM Healthcare Investments | 52,916,667 | 9.9% | 9.9% |
Fjärde AP-fonden | 52,314,074 | 9.8% | 9.8% |
Handelsbanken Funds | 24,823,994 | 4.7% | 4.7% |
Avanza Pension | 20,321,109 | 3.8% | 3.8% |
SEB-Stiftelsen | 19,047,617 | 3.6% | 3.6% |
SEB Life International | 13,927,350 | 2.6% | 2.6% |
SEB Venture Capital | 12,994,367 | 2.4% | 2.4% |
Stiftelsen Industrifonden | 12,865,296 | 2.4% | 2.4% |
Nordnet Pensionsförsäkring | 11,235,048 | 2.1% | 2.1% |
Swedbank försäkring AB | 10,405,793 | 2.0% | 2.0% |
S-E-Bankens Utvecklingsstiftelse | 10,000,000 | 1.9% | 1.9% |
Staffan Rasjö | 8,898,097 | 1.7% | 1.7% |
Originat AB | 7,000,000 | 1.3% | 1.3% |
Ponderus Invest AB | 5,719,085 | 1.1% | 1.1% |
Other | 200,298,586 | 37.6% | 37.6% |
Total | 532,687,650 | 100,0% | 100,0% |